Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.86M
March 31, 2026 -0.91M
December 31, 2025 -0.907M
September 30, 2025 -0.86M
June 30, 2025 -0.806M
March 31, 2025 -0.918M
December 31, 2024 -0.942M
September 30, 2024 -0.937M
June 30, 2024 -1.102M
March 31, 2024 -1.046M
December 31, 2023 -1.16M
September 30, 2023 -1.287M
June 30, 2023 -1.108M
Date Value
March 31, 2023 -0.998M
December 31, 2022 -0.818M
September 30, 2022 -0.629M
June 30, 2022 -0.545M
March 31, 2022 -0.555M
December 31, 2021 -0.601M
September 30, 2021 -0.667M
June 30, 2021 -0.778M
March 31, 2021 -0.786M
December 31, 2020 -0.815M
September 30, 2020 -0.616M
June 30, 2020 -0.418M
March 31, 2020 -0.222M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Myriad Genetics, Inc. 525.10M
BioRestorative Therapies, Inc. 0.119M
CareDx, Inc. 321.18M
Natera, Inc. 1.753B
Exagen, Inc. 41.70M